BIOC-51

N/A

Report date: 2023/01/06 10:06:52
QIDP

Base Information

Drug NameBIOC-51
Drug Alias NameBIOC-51
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsCystic FibrosisBovine Respiratory Disease ComplexAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVast Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVast Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystic FibrosisBovine Respiratory Disease ComplexAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A